Journal of Cardiac Failure最新文献

筛选
英文 中文
Changes in Seated Pulmonary Artery Pressure in Response to Titration of Heart Failure Medications During Ambulatory Monitoring.
IF 6.7 2区 医学
Journal of Cardiac Failure Pub Date : 2025-02-11 DOI: 10.1016/j.cardfail.2025.02.001
Sandip K Zalawadiya, Michael Kiernan, Barry A Borlaug, Lynne Warner Stevenson, Akshay S Desai, Mosi Bennett, Wilfried Mullens, Nicholas J Hiivala, Max M Owens, Liviu Klein
{"title":"Changes in Seated Pulmonary Artery Pressure in Response to Titration of Heart Failure Medications During Ambulatory Monitoring.","authors":"Sandip K Zalawadiya, Michael Kiernan, Barry A Borlaug, Lynne Warner Stevenson, Akshay S Desai, Mosi Bennett, Wilfried Mullens, Nicholas J Hiivala, Max M Owens, Liviu Klein","doi":"10.1016/j.cardfail.2025.02.001","DOIUrl":"10.1016/j.cardfail.2025.02.001","url":null,"abstract":"<p><strong>Introduction: </strong>Ambulatory hemodynamic monitoring (AHM) of heart failure (HF) using pulmonary artery pressure (PAP) is marked by frequent changes in HF medications. We are beginning to learn how medication titrations during AHM affect mean PAP (mPAP) measured in the seated position, which reflects most waking hours.</p><p><strong>Method: </strong>We analyzed the 12-month data from the PROACTIVE-HF trial of the Cordella Cordella, Endotronix Inc, Naperville, Illinois, United States) PAP sensor system. Seated mPAP was examined in the 14-days before and after isolated changes in medications; only those medications with ≥10 titrations were analyzed. Dependent sample Wilcoxon-signed rank test was used to compare changes in mPAP with titrations.</p><p><strong>Results: </strong>We analyzed 456 subjects (age: 64 years, females: 40%, Black: 18%, HF with reduced ejection fraction: 46%). Loop diuretics (LD) were up-titrated 176 times in 133 patients and down-titrated 113 times in 96 patients. Before LD up-titration, mPAP increased by 1.6 ± 1.0 mm Hg; afterwards, it decreased by 2.3 ± 1.0 mm Hg (P < 0.001), with most reduction occurring within 1 week. Down-titration of LD was followed by an increase of 1.8 ± 1.3 mm Hg (P = 0.004) over the next several days. Similar trends were observed across categories of ejection fraction (≤40% and >40%). Angiotensin receptor neprilysin inhibitor (ARNI) up-titration decreased mPAP by 1.8 ± 1.9 mm Hg (P = 0.042), whereas down-titration increased mPAP by 1.5 ± 1.4 (P = 0.094). Mineralocorticoid receptor antagonist (MRA) up-titration tended to decrease mPAP (1.6 ± 2.5 mm Hg, P = 0.286,) whereas down-titration was followed by a significant increase in mPAP of 3.2 ± 1.6 mm Hg (P = 0.001).</p><p><strong>Conclusion: </strong>The AHM platform using seated mPAP data provided valuable insights into its short-term responses to isolated changes in HF medications. The seated mPAP changed expectedly in response to the titration of LD, whereas the degree of response varied for ARNI and MRA. Ongoing investigation will further characterize the timing and variability of responses to inform algorithms for ambulatory management of PAP.</p>","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":" ","pages":""},"PeriodicalIF":6.7,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143414410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Question in the Era of Multiple Effective Therapies for Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Is Transthyretin Biology a Driver of Disease Progression?
IF 6.7 2区 医学
Journal of Cardiac Failure Pub Date : 2025-02-11 DOI: 10.1016/j.cardfail.2025.01.015
Mathew S Maurer
{"title":"A Question in the Era of Multiple Effective Therapies for Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Is Transthyretin Biology a Driver of Disease Progression?","authors":"Mathew S Maurer","doi":"10.1016/j.cardfail.2025.01.015","DOIUrl":"10.1016/j.cardfail.2025.01.015","url":null,"abstract":"","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":" ","pages":""},"PeriodicalIF":6.7,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143414409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is Peak Exercise Performance Relevant to Trials of Patients With HFpEF?
IF 6.7 2区 医学
Journal of Cardiac Failure Pub Date : 2025-02-11 DOI: 10.1016/j.cardfail.2025.01.018
Yogesh N V Reddy
{"title":"Is Peak Exercise Performance Relevant to Trials of Patients With HFpEF?","authors":"Yogesh N V Reddy","doi":"10.1016/j.cardfail.2025.01.018","DOIUrl":"10.1016/j.cardfail.2025.01.018","url":null,"abstract":"","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":" ","pages":""},"PeriodicalIF":6.7,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143414417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PCWL: A Compelling Hemodynamic Metric in Advancing HFpEF Diagnosis.
IF 6.7 2区 医学
Journal of Cardiac Failure Pub Date : 2025-02-11 DOI: 10.1016/j.cardfail.2025.02.005
Molly K Silkowski, Ryan J Tedford, Javed Butler, Brian A Houston
{"title":"PCWL: A Compelling Hemodynamic Metric in Advancing HFpEF Diagnosis.","authors":"Molly K Silkowski, Ryan J Tedford, Javed Butler, Brian A Houston","doi":"10.1016/j.cardfail.2025.02.005","DOIUrl":"10.1016/j.cardfail.2025.02.005","url":null,"abstract":"","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":" ","pages":""},"PeriodicalIF":6.7,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143414419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reprieve System for the Treatment of Patients With Acute Decompensated Heart Failure.
IF 6.7 2区 医学
Journal of Cardiac Failure Pub Date : 2025-02-11 DOI: 10.1016/j.cardfail.2025.02.002
Juan B Ivey-Miranda, Veena S Rao, Tamaz Shaburishvili, Ivlita Verulava, Nina Khabeishvili, Mark C Petrie, Javed Butler, Julio Nunez, Jan Biegus, Piotr Ponikowski, Kevin Damman, Sean P Collins, Jeffrey M Testani, Zachary L Cox
{"title":"Reprieve System for the Treatment of Patients With Acute Decompensated Heart Failure.","authors":"Juan B Ivey-Miranda, Veena S Rao, Tamaz Shaburishvili, Ivlita Verulava, Nina Khabeishvili, Mark C Petrie, Javed Butler, Julio Nunez, Jan Biegus, Piotr Ponikowski, Kevin Damman, Sean P Collins, Jeffrey M Testani, Zachary L Cox","doi":"10.1016/j.cardfail.2025.02.002","DOIUrl":"10.1016/j.cardfail.2025.02.002","url":null,"abstract":"","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":" ","pages":""},"PeriodicalIF":6.7,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143414432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Underpinnings of Heart Failure With Preserved Ejection Fraction in Women - From Prevention to Improving Function. A Co-publication With the American Journal of Preventive Cardiology and the Journal of Cardiac Failure.
IF 6.7 2区 医学
Journal of Cardiac Failure Pub Date : 2025-02-10 DOI: 10.1016/j.cardfail.2025.01.008
Ankitha Radakrishnan, Saloni Agrawal, Nausheen Singh, Anna Barbieri, Leslee J Shaw, Martha Gulati, Anuradha Lala
{"title":"Underpinnings of Heart Failure With Preserved Ejection Fraction in Women - From Prevention to Improving Function. A Co-publication With the American Journal of Preventive Cardiology and the Journal of Cardiac Failure.","authors":"Ankitha Radakrishnan, Saloni Agrawal, Nausheen Singh, Anna Barbieri, Leslee J Shaw, Martha Gulati, Anuradha Lala","doi":"10.1016/j.cardfail.2025.01.008","DOIUrl":"https://doi.org/10.1016/j.cardfail.2025.01.008","url":null,"abstract":"<p><p>Heart failure with preserved ejection fraction (HFpEF) represents a major clinical challenge with rising global prevalence. Women have a nearly double lifetime risk of developing HFpEF compared to heart failure with reduced ejection fraction (HFrEF). In HFpEF, sex differences emerge both in how traditional cardiovascular risk factors (such as hypertension, obesity, and diabetes) affect cardiac function and through distinct pathophysiological mechanisms triggered by sex-specific events like menopause and adverse pregnancy outcomes. These patterns influence not only disease development, but also therapeutic responses, necessitating sex-specific approaches to treatment. This review aims to synthesize existing knowledge regarding HFpEF in women including traditional and sex-specific risk factors, pathophysiology, presentation, and therapies, while outlining important knowledge gaps that warrant further investigation. The impact of HFpEF spans a woman's entire lifespan, requiring prevention and management strategies tailored to different life stages. While understanding of sex-based differences in HFpEF has improved, significant knowledge gaps persist. Through examination of current evidence and challenges, this review highlights promising opportunities for innovative research, therapeutic development, and clinical care approaches that could transform the management of HFpEF in women.</p>","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":" ","pages":""},"PeriodicalIF":6.7,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143458132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Emerging Myth of Primary Graft Dysfunction in the Era of Advanced Organ Preservation in Heart Transplantation.
IF 6.7 2区 医学
Journal of Cardiac Failure Pub Date : 2025-02-06 DOI: 10.1016/j.cardfail.2025.01.013
Nicole K Bart, Andreas Zuckermann, Mandeep R Mehra
{"title":"The Emerging Myth of Primary Graft Dysfunction in the Era of Advanced Organ Preservation in Heart Transplantation.","authors":"Nicole K Bart, Andreas Zuckermann, Mandeep R Mehra","doi":"10.1016/j.cardfail.2025.01.013","DOIUrl":"10.1016/j.cardfail.2025.01.013","url":null,"abstract":"","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":" ","pages":""},"PeriodicalIF":6.7,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143373809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating Incident Atrial Fibrillation and Incident Heart Failure as Time-varying Covariates for Time-to-Event Analysis Among Adults 55 Years and Older in the Multi-Ethnic Study of Atherosclerosis (MESA).
IF 6.7 2区 医学
Journal of Cardiac Failure Pub Date : 2025-02-03 DOI: 10.1016/j.cardfail.2025.01.012
Pierre J Amiel, Bharath Ambale-Venkatesh, Colin O Wu, Matthew Matheson, Mohammad R Ostovaneh, João A C Lima, Christopher F Cox
{"title":"Evaluating Incident Atrial Fibrillation and Incident Heart Failure as Time-varying Covariates for Time-to-Event Analysis Among Adults 55 Years and Older in the Multi-Ethnic Study of Atherosclerosis (MESA).","authors":"Pierre J Amiel, Bharath Ambale-Venkatesh, Colin O Wu, Matthew Matheson, Mohammad R Ostovaneh, João A C Lima, Christopher F Cox","doi":"10.1016/j.cardfail.2025.01.012","DOIUrl":"10.1016/j.cardfail.2025.01.012","url":null,"abstract":"<p><strong>Objectives: </strong>Heart failure (HF) and atrial fibrillation (AF) frequently coexist, exacerbate each other and are associated with increased morbidity and mortality rates. However, no previous study has specifically calculated the risk of experiencing either event following the occurrence of the other and also considered competing risks. The aim of this study was to examine the bidirectional relationship of AF and HF in a multiethnic population, taking competing risks into account.</p><p><strong>Methods: </strong>Two Fine and Gray regression models of the subdistribution functions were implemented to evaluate the bidirectional association between AF and HF and were adjusted for a common set of covariates. Competing events were defined as HF/AF and/or cardiac death vs noncardiac death. For each model, common covariates for AF and HF were pre-identified in the literature, and either HF or AF was used as a time-dependent covariate.</p><p><strong>Results: </strong>In the Multi-Ethnic Study of Atherosclerosis (MESA), 4016 study participants (mean age 67.2 ± 7.6 years and 48.8% male participants), free of clinically recognized cardiovascular disease at baseline, were assessed for AF and HF. After a median (IQR) follow-up of 6034 (3994-6313) days, 1044 incident AFs, 302 incident HFs and 1298 events of death occurred. Deaths were distributed as 313 cardiac deaths and 985 noncardiac deaths, and the incidence of AF was about 3.5 higher than that of HF. We found that HF was associated with a composite outcome of AF and/or cardiac death (HR 2.91, 95%CI [2.49-3.40]; P < 0.001) and that AF was associated with a composite outcome of HF and/or cardiac death (HR 2.05, 95%CI [1.79-2.35]; P < 0.001).</p><p><strong>Conclusion: </strong>AF and HF exacerbate the incidence of each other and are strongly and independently associated, suggesting that their joint association should be taken into consideration in future studies. From a clinical perspective, the occurrence of either of these events greatly increases the risk for the other (ClinicalTrials.gov Identifier: NCT00005487).</p>","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":" ","pages":""},"PeriodicalIF":6.7,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143255700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Unlocking the Prognostic Potential: the Quest for Optimal Right Ventricular Parameters in LVAD Recipients 社论:释放预后潜力:探索 LVAD 受术者的最佳右心室参数。
IF 6.7 2区 医学
Journal of Cardiac Failure Pub Date : 2025-02-01 DOI: 10.1016/j.cardfail.2024.11.004
ANIQUE DUCHARME MD, MSc , MOHAMMED IMRAN ASLAM MD
{"title":"Editorial: Unlocking the Prognostic Potential: the Quest for Optimal Right Ventricular Parameters in LVAD Recipients","authors":"ANIQUE DUCHARME MD, MSc ,&nbsp;MOHAMMED IMRAN ASLAM MD","doi":"10.1016/j.cardfail.2024.11.004","DOIUrl":"10.1016/j.cardfail.2024.11.004","url":null,"abstract":"","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 2","pages":"Pages 397-399"},"PeriodicalIF":6.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142638048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis Following Left Ventricular Assist Device Implantation 心脏结节病患者左心室辅助装置植入后的室性心律失常。
IF 6.7 2区 医学
Journal of Cardiac Failure Pub Date : 2025-02-01 DOI: 10.1016/j.cardfail.2024.10.442
FRANCISCA BERMUDEZ BS , ALEXANDER A. RIZK MD , MANISH H. SHAH MD , FAROOQ H. SHEIKH MD , CONNOR P. OATES MD
{"title":"Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis Following Left Ventricular Assist Device Implantation","authors":"FRANCISCA BERMUDEZ BS ,&nbsp;ALEXANDER A. RIZK MD ,&nbsp;MANISH H. SHAH MD ,&nbsp;FAROOQ H. SHEIKH MD ,&nbsp;CONNOR P. OATES MD","doi":"10.1016/j.cardfail.2024.10.442","DOIUrl":"10.1016/j.cardfail.2024.10.442","url":null,"abstract":"","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 2","pages":"Pages 485-488"},"PeriodicalIF":6.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142780020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信